A Commentary on Several Study Design Considerations Pertaining to the Screening of Substances Extracted and/or Leached from Pharmaceutical Contact Materials

References

1. 1.↵
   U.S. Pharmacopeial Convention. General Chapter <1225>. Validation of Compendial Methods. USP29–NF24, USP: Rockville, MD, 2016.
2. 2.↵
   International Conference on Harmonization. Validation of Analytical Procedures. Q2.
3. 3.↵
   Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics (III:B:1:c); U.S. Department of Health and Human Services, Food and Drug Administration; Rockville, MD, 1999.
4. 4.↵
   Current Good Manufacturing Practices for Finished Pharmaceuticals: Control of Components and Drug Product Containers and Closures. Code of Federal Regulations, Title 1, Volume 4, Subpart E, Section 211.94, 2019.
5. 5.↵
   1. Jenke D.

   Compatibility of Pharmaceutical Products and Contact Materials, John Wiley & Sons: Hoboken, NJ, 2009; p 40.
6. 6.↵
   1. Jenke D.,
   2. Rabinow B. E.

   Proper Accounting for Surface Area to Solution Volume Ratios in Exaggerated Extractions. PDA J. Pharm. Sci. Tech. 2017, 71 (3), 225–233.

   OpenUrl
7. 7.↵
   International Organization for Standardization (ISO). Biological Evaluation of Medical Devices—Part 12: Sample Preparation and Reference Materials. ISO 10993-12:2012; 2012.
8. 8.↵
   Extractables testing of polymeric single-use components used in biopharmaceutical manufacturing. BioPhorum. 2020. www.biophorum.com.
9. 9.
   1. Zdravkovic S. A.,
   2. Duong C. T.,
   3. Hellenbrand A. A.,
   4. Duff S. R.,
   5. Dreger A. L.

   Establishment of a Reference Standard Database for Use in the Qualitative and Semi-Quantitative Analysis of Pharmaceutical Contact Materials within an Extractables Survey by GC-MS. J. Pharm. Biomed. Anal. 2018, 151, 49–60.

   OpenUrl
10. 10.↵
    1. Jenke D.

    Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables. PDA J. Pharm. Sci. Tech. 2020, 74 (3), 348–358.

    OpenUrl
11. 11.↵
    1. Jenke D.,
    2. Heise T.

    The Implications of Chromatographically Screening Medical Products for Organic Leachables down to the AET Adjusted for Response Factor Variation. PDA J. Pharm. Sci. Tech. 2021, 75 (3), 273–288.

    OpenUrl
12. 12.↵
    1. Jordi M. A.,
    2. Khera S.,
    3. Roland K.,
    4. Jiang L.,
    5. Solomon P.,
    6. Nelson J.,
    7. Lateef S. S.,
    8. Woods J.,
    9. Martin L.,
    10. Martin S.,
    11. Aiello F.,
    12. Chen N.

    Qualitative Assessment of Extractables from Single-Use Components and the Impact of Reference Standard Selection. J. Pharm. Biomed. Anal. 2018, 150, 368–376.

    OpenUrl
13. 13.↵
    1. Jordi M. A.,
    2. Heise T.

    An Analytical Strategy Based on Multiple Complementary and Orthogonal Chromatographic and Detection Methods (Multidetector Approach) to Effectively Manage the Analytical Evaluation Threshold (AET). PDA J. Pharm. Sci. Tech. 2021, 75 (3), 289–301.

    OpenUrl
14. 14.↵
    1. Jordi M. A.,
    2. Rowland K.,
    3. Liu W.,
    4. Cao W.,
    5. Zong J.,
    6. Ren Y.,
    7. Liang Z.,
    8. Zhou X.,
    9. Louis M.,
    10. Lerner K.

    Reducing Relative Response Factor Variation Using a Multidetector Approach for Extractables and Leachables (E&L) Analysis to Mitigate the Need for Uncertainty Factors. J. Pharm. Biomed. Anal. 2020, 186, 113334.

    OpenUrl